Cano Research - Cano Health

Research Today for A Better Tomorrow

Who we are

Cano Research is the clinical research arm of Cano Health that focuses on providing new and innovative treatments and diagnostic tests for our patients. We also provide opportunities for our patients to participate in academic and outcomes-based research in our network.

Why Cano Research

The patient population at Cano Health is largely diverse and allows Cano Research to attract studies that are tailored to the most common diseases in our patient population.

What is a clinical trial?

A clinical trial is a research study where volunteers receive new medication or treatments that are being studied under the supervision of a physician or other research professionals. The study tests the safety and effectiveness of new cutting-edge medications and medical treatments to determine the benefits. The treatments are developed by pharmaceutical and biotechnological companies that select qualified physicians, that are also referred to as investigators during the study. The clinical trial allows volunteers the opportunity to try new innovative treatments not available to everyone while being closely monitored and evaluated.

Who can participate in a clinical trial?

Clinical trials have different guidelines that dictate who is considered a qualifying participant. Criteria such as age, gender, type and stage of disease, previous treatment history, and other medical conditions are taken into review and seperated into “inclusion” and “exclusion” criteria. Those that qualify as participants are placed in the “inclusion” criteria. Some research studies seek individuals with specific illnesses or conditions to be part of a clinical trial, while others require healthy participants. Inclusion and exclusion criteria are used to identify appropriate participants, promote their safety, and ensure the information researchers gather is suitable.

Does information remain confidential?

Access to personal information is usually available to the investigator and research team conducting the clinical trial. In some circumstances, the Institutional Review Board (IRB) overseeing the research, the sponsor, and contract research organization coordinating the trial will also have access to personal information. This is explained more specifically to participating volunteers in the consent form they are asked to sign. As the clinical trial progresses, researchers report results during scientific meetings, to medical journals, and various government agencies. Volunteers in a clinical trial participate in the development of medical therapies that may offer better treatments and even cures for life-threatening and chronic diseases.

How does a clinical trial work?

Once established as a qualifying participant, volunteers are assigned to specific study groups. Treatments are then administered to volunteers. Those in one study group may receive an investigational treatment or study drug, while other volunteers may receive a placebo or a treatment already available. This allows the physician and research staff to objectively observe volunteers during the study. Regardless of which treatment volunteers receive, the level of medical attention and care is the same.

Are there any benefits in volunteering?

Yes, there are benefits to volunteering for a clinical trial. Participants play an active role in the development of new healthcare treatments. They also gain access to research treatments before they are widely available while obtaining necessary medical care at the healthcare facilities during the trial.

What are the possible risks in volunteering?

Clinical trials involve government regulations and an IRB to monitor and approve biomedical research involving human subjects. The rights and well-being of the participants ensure the benefits outweigh the risks. However, some of the risks involved include:

There may be unpleasant, serious, or even life-threatening side effects to experimental treatment
The experimental treatment may not prove effective
The protocol treatment time and attention are not always certain and may require additional trips to the site, more treatments, hospital stays, or complex dosage requirements

Clinical Trials

We conduct phase I-IV trials for five vital diseases:

Clinical subjects at Cano Research have access to a wide array of clinical trials. Cano Health physicians serve as investigators for both Phase II and Phase III clinical trials for the following disease states:

Cardiovascular Disease
Alzheimer’s and Dementia
Diabetes Mellitus
Lung Cancer
Obesity

Cardiovascular Disease

Alzheimer’s and Dementia

Diabetes Mellitus

Lung Cancer

Obesity

Benefits of Clinical Trials

Cano Research exclusively focuses on Phase II through IV, which allows our patients the opportunity to take advantage of the newest, most advanced treatments for their disease. Clinical trials are strictly regulated by the government to ensure patient safety is protected and to make sure every patient involved in a clinical trial receives the standard of care.

There are direct benefits patients may gain from participating in a clinical trial. This can include the possibility of better results from their treatment. Also, participants can feel good knowing they are playing an important part in advancing scientific discovery and making progress towards better, more effective treatments for cancer.

Phase II

Phase II trials involve more participants than Phase I trials and are designed to test both the safety and effectiveness of new treatments. These trials are instrumental to the development of cutting-edge treatments and form a part of the clinical studies portfolio of Cano Research.

Phase III

Phase III studies are the final step before seeking regulatory approval for a new treatment from organizations like the Food & Drug Administration (FDA). These trials include large populations of patients and can last multiple years. During Phase III trials, scientists, also called investigators both identify any side effects that were not observed during the Phase II trial, as well as examine the efficacy of the investigational treatment against the current standard of care.

Phase IV

Phase IV clinical trials are long-term safety and efficacy trials that occurs after the investigational treatment has been approved by the FDA.